Acute Chest Syndrome: Reference List
Chou, S. T., Alsawas, M., Fasano, R. M., Field, J. J., Hendrickson, J. E., Howard, J., Kameka, M., Kwiatkowski, J. L., Pirenne, F., Shi, P. A., Stowell, S. R., Thein, S. L., Westhoff, C. M., Wong, T. E., & Akl, E. A. (2020, Jan 28). American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv, 4(2), 327-355. https://doi.org/10.1182/bloodadvances.2019001143
Expert Panel. (2014). Evidence-based management of Sickle Cell Disease. U.S. Department of Health and Human Services. https://www.nhlbi.nih.gov/sites/default/files/media/docs/sickle-cell-disease-report%20020816_0.pdf
Miller, S. T. (2011, May 19). How I treat acute chest syndrome in children with sickle cell disease. Blood, 117(20), 5297-5305. https://doi.org/10.1182/blood-2010-11-261834
Munaretto, V., Colombatti, R., Tripodi, S. I., Paola, C., Cesaro, S., Arcioni, F., Piccolo, C., Mina, T., Zecca, M., Cuzzubbo, D., Casale, M., Palazzi, G., Notarangelo, L., Masera, N., Russo, G., & Sainati, L. (2019). Acute Chest Syndrome in Children with Sickle Cell Disease in Italy: Results of a National Survey from the Italian Association of Pediatric Hematology Oncology (AIEOP). Blood, 134(Supplement_1), 2301-2301. https://doi.org/10.1182/blood-2019-128215
These pathways do not establish a standard of care to be followed in every case. It is recognized that each case is different, and those individuals involved in providing health care are expected to use their judgment in determining what is in the best interests of the patient based on the circumstances existing at the time. It is impossible to anticipate all possible situations that may exist and to prepare a pathway for each. Accordingly, these pathways should guide care with the understanding that departures from them may be required at times.